Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A.
- DOI
- 10.1089/hum.2021.108
- Published
- 2022 Apr
- Container
- Human gene therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1089/hum.2021.108,
title = {Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A.},
author = {Greig JA and Smith MK and Nordin JML and Goode T and Chroscinski EA and Buza EL and Schmidt N and Kattenhorn LM and Wadsworth S and Wilson JM},
year = {2022},
journal = {Human gene therapy},
doi = {10.1089/hum.2021.108},
url = {https://doi.org/10.1089/hum.2021.108}
}RIS
TY - JOUR TI - Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A. AU - Greig JA AU - Smith MK AU - Nordin JML AU - Goode T AU - Chroscinski EA AU - Buza EL AU - Schmidt N AU - Kattenhorn LM AU - Wadsworth S AU - Wilson JM PY - 2022 JO - Human gene therapy DO - 10.1089/hum.2021.108 UR - https://doi.org/10.1089/hum.2021.108 ER -
APA
JA, G., MK, S., JML, N., T, G., EA, C., EL, B., N, S., LM, K., S, W., & JM, W. (2022). Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A.. Human gene therapy. https://doi.org/10.1089/hum.2021.108
Source records
- pubmed · retrieved 2026-09-25T23:37:45.147Z